v-ATPase V0 subunit d2–deficient mice exhibit impaired osteoclast fusion and increased bone formation
Seoung-Hoon Lee(University of Pennsylvania), Yongwon Choi(University of Pennsylvania), Takeshi Miyamoto(Kumamoto Health Science University), Daewon Jeong(Yeungnam University Medical Center), Sun‐Kyeong Lee(UConn Health), Robert J. Pignolo(Mayo Clinic in Arizona), Boguslawa Koczon-Jaremko(UConn Health), Nacksung Kim(Chonnam National University), Toshio Suda(Chinese Academy of Sciences), Jaerang Rho(Chungnam National University), Jai-Yoon Sul(University of Pennsylvania), Tae Soo Kim(Seoul National University), Ju-Seob Kang(University of Pennsylvania), Joseph Lorenzo(UConn Health)
Cited by 542
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
|EBioMedicine|2019|1.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771